SC Pharmaceuticals
0026938.792.33% ( +0.20 )
SC Pharmaceuticals (002693)
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw...
- Open
- 8.58
- High
- 8.79
- Low
- 8.57
- Prev. Close
- 8.59
- Volume
- 118.14K
- Turnover
- 102.85M
- Avg Price
- 8.71
- Bid/Ask Ratio
- --
- Amplitude
- 2.56%
- 52wk High
- 12.43
- Volume Ratio
- 0.35
- Turnover Ratio
- 2.85%
News
- Zhitong · Aug 26, 2025 at 04:00 AM
ST SC Pharmaceuticals: Passed the drug GMP compliance inspection
- Zhitong · Jul 30, 2025 at 03:44 AM
ST SC Pharmaceuticals released its half-year performance, with a net loss attributable to shareholders of 18.4666 million yuan, an increase of 8.97%
- Zhitong · May 19, 2025 at 04:57 AM
ST SC Pharmaceuticals: Eptinezumab injection has obtained marketing authorization from the Therapeutic Goods Administration (TGA) of Australia
- Zhitong · May 16, 2025 at 04:32 AM
ST SC Pharmaceuticals: Injectable Paclitaxel (Albumin-Bound) ANDA approved for market by the U.S. FDA
- Zhitong · May 6, 2025 at 05:10 AM
ST SC Pharmaceuticals: Injectable Bivalirudin has obtained market approval from the Therapeutic Goods Administration (TGA) of Australia
- Zhitong · Apr 27, 2025 at 08:30 PM
CRO concept stocks opened lower, SC Pharmaceuticals and Sinobioway Medicine hit the daily limit down
